Not Yet RecruitingNot Applicable

Circulating Factors in Nephrotic Syndrome

104 participantsStarted 2024-04-01

Plain-language summary

A prospective observational study to investigate the treatment-associated changes of circulating factors associated with glomerular diseases among patients with de novo nephrotic syndrome admitted to hospital for a kidney biopsy.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥ 18 years * Plasma albumin \< 36 g/L * Urine protein \>3.5 g/day or urine protein/creatinine-ratio (UPCR) \> 3.5 or urine albumin/creatinine-ratio (UACR) \>2200 mg/g * Planned kidney biopsy * Able to give written informed consent Exclusion Criteria: * Kidney transplant recipient * Previously undergone a kidney biopsy * Unable to understand written information in Danish

What they're measuring

levels of anti-nephrin in blood by ELISA

Timeframe: up to 12 months

Trial details

NCT IDNCT06315504

SponsorIain Bressendorff

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2034-04-01

Contact for this trial

Iain Bressendorff, MD PhD

+4524277139 iain.oshoej.bressendorff@regionh.dk

View on ClinicalTrials.gov More Nephrotic Syndrome trials